1. Weingart, SN, Brown, E, Bach, PB, et al. NCCN Task force report: oral chemotherapy. J Natl Compr Canc Netw 2008; 6: 1–14.
Google Scholar | Crossref | Medline2. Neuss, MN, Polovich, M, McNiff, K, et al. Updated American society of clinical oncology/oncology nursing society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapy. J Oncol Pract. 2013; 2013: 5–13.
Google Scholar | Crossref3. Mackler, E, Segal, EM, Muluneh, B, et al. Hematology/oncology pharmacist association best practices for the management of oral oncolytic therapy: pharmacy practice standard. J Oncol Pract 2018; 2019: 346–355.
Google Scholar4. Berger, NA, Savvides, P, Koroukian, SM, et al. Cancer in the elderly. Trans Am Clin Climatol Assoc 2006; 117: 147–155.
Google Scholar | Medline5. Shrestha, S, Shrestha, S, Khanal, S. Polypharmacy in elderly cancer patients: challenges and the way clinical pharmacists can contribute in resource-limited settings. Aging Med (Milton) 2019; 2: 42–49.
Google Scholar | Crossref | Medline6. Maggiore, RJ, Gross, CP, Hurria, A. Polypharmacy in older adults with cancer. Oncologist 2010; 15: 507–522.
Google Scholar | Crossref | Medline7. LeBlanc, TW, McNeil, MJ, Kamal, AH, et al. Polypharmacy in patients with advanced cancer and the role of medication discontinuation. Lancet Oncol. 2015; 16: 333–341.
Google Scholar | Crossref | Medline8. Sweet, E, Dowd, F, Zhou, M, et al. The Use of complementary and alternative medicine supplements of potential concern during breast cancer chemotherapy. Evid Based Complement Alternat Med. 2016; 4382687.
Google Scholar9. Herledan, C, Baudouin, A, Larbre, V, et al. Clinical and economic impact of medication reconciliation in cancer patients: a systematic review. Support Care Cancer 2020; 28: 3557–3569.
Google Scholar | Crossref | Medline10. Alomar, MJ . Factors affecting the development of adverse drug reactions (review article). Saudi Pharm J 2014; 22: 83–94.
Google Scholar | Crossref | Medline11. Bates, DW, Cullen, DJ, Laird, N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. Jama. 1995; 274: 29–34.
Google Scholar | Crossref | Medline | ISI12. Beijer, HJ, de Blaey, CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002; 24: 46–54.
Google Scholar | Crossref | Medline13. Ribed, A, Romero-Jimenez, RM, Escudero-Vilaplana, V, et al. Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction. Int J Clin Pharm. 2016; 38: 280–288.
Google Scholar | Crossref | Medline14. Shah, S, Dowell, J, Fau - Greene, S, et al. Evaluation of clinical pharmacy services in a hematology/oncology outpatient setting. Ann Pharmacother. 2006; 40: 1527–1533.
Google Scholar | SAGE Journals | ISI15. Wong, SF, Bounthavong, M, Nguyen, C, et al. Implementation and preliminary outcomes of a comprehensive oral chemotherapy management clinic. Am J Health Syst Pharm. 2014; 71: 960–965.
Google Scholar | Crossref | Medline | ISI16. Lam, MS, Cheung, N. Impact of oncology pharmacist-managed oral anticancer therapy in patients with chronic myelogenous leukemia. J Oncol Pharm Pract. 2016; 22: 741–748.
Google Scholar | SAGE Journals | ISI17. Kimura, M, Go, M, Iwai, M, et al. Evaluation of the role and usefulness of a pharmacist outpatient service for patients undergoing monotherapy with oral anti-cancer agents. J Oncol Pharm Pract. 2017; 23: 413–421.
Google Scholar | SAGE Journals | ISI18. Whitman, AM, DeGregory, KA, Morris, AL, et al. A comprehensive Look at polypharmacy and medication screening tools for the older cancer patient. Oncologist 2016 Jun; 21: 723–730.
Google Scholar | Crossref | Medline19. Huiskes, VJB, Burger, DM, van den Ende, CHM, et al. Effectiveness of medication review: a systematic review and meta-analysis of randomized controlled trials. BMC Family Practice. 2017; 18: 5.
Google Scholar | Crossref | Medline20. Switten, L . Geneesmiddelendiscrepanties bij opname: Wat is het belang van een farmaceutische anamnese? Master Thesis, Katholieke Universiteit Leuven, Belgium, 2018.
Google Scholar21. Somers, A, Mallet, L, van der Cammen, T, et al. Applicability of an adapted medication appropriateness index for detection of drug-related problems in geriatric inpatients. Am J Geriatr Pharmacother 2012; 10: 101–109.
Google Scholar | Crossref | Medline22. Verheyen, S, Wuyts, S, Collier, H, et al. Development of a Belgian classification system for clinical pharmacy activities. European Journal of Hospital Pharmacy 2020: A126–A1A7.
Google Scholar23. UZ Brussel . Ziekenhuisapotheek - Farmaceutische zorg 2021, https://www.uzbrussel.be/web/apotheek/farmaceutische-zorg (2021, accessed 23 April 2021).
Google Scholar24. WHO Collaborating Centre for Drug Statistic Methodology . ATC/DDD Index 2020, https://www.whocc.no/atc_ddd_index/ (2020, accessed 25 April 2020).
Google Scholar25. Vega, TG, Sierra-Sanchez, JF, Martinez-Bautista, MJ, et al. Medication reconciliation in oncological patients: a randomized clinical trial. J Manag Care Spec Pharm 2016; 22: 734–740.
Google Scholar | Crossref | Medline26. Phan, H, Williams, M, McElroy, K, et al. Implementation of a student pharmacist-driven medication history service for ambulatory oncology patients in a large academic medical center. J Oncol Pharm Pract. 2019; 25: 1419–1424.
Google Scholar | SAGE Journals | ISI27. Ashjian, E, Salamin, LB, Eschenburg, K, et al. Evaluation of outpatient medication reconciliation involving student pharmacists at a comprehensive cancer center. J Am Pharm Assoc (2003). 2015; 55: 540–545.
Google Scholar | Crossref | Medline28. Weingart, SN, Cleary, A, Seger, A, et al. Medication reconciliation in ambulatory oncology. Jt Comm J Qual Patient Saf. 2007; 33: 750–757.
Google Scholar | Crossref | Medline29. Somers, A, Clottens, N, Lesage, D, et al. Seamless pharmaceutical care for patients using oral chemotherapy agents: a pilot study, https://www.health.belgium.be/sites/default/files/uploads/fields/fpshealth_theme_file/12._seamless_pharmaceutical_care_oral_chemotherapy_agents_-_uz_gent.pdf (accessed 28 May 2020).
Google Scholar30. Bertsch, NS, Bindler, RJ, Wilson, PL, et al. Medication therapy management for patients receiving oral chemotherapy agents at a community oncology center: a pilot study. Hosp Pharm. 2016; 51: 721–729.
Google Scholar | SAGE Journals31. Kraus, SK, Sen, S, Murphy, M, et al. Impact of a pharmacy technician-centered medication reconciliation program on medication discrepancies and implementation of recommendations. Pharm Pract (Granada). 2017; 15: 901.
Google Scholar | Crossref | Medline32. Bulsink, A, Imholz, AL, Brouwers, JR, et al. Characteristics of potential drug-related problems among oncology patients. Int J Clin Pharm. 2013; 35: 401–407.
Google Scholar | Crossref | Medline | ISI33. Somers, A, Robays, H, De Paepe, P, et al. Evaluation of clinical pharmacist recommendations in the geriatric ward of a Belgian university hospital. Clin Interv Aging. 2013; 8: 703–709.
Google Scholar | Crossref | Medline34. Nielsen, TR, Andersen, SE, Rasmussen, M, et al. Clinical pharmacist service in the acute ward. Int J Clin Pharm. 2013; 35: 1137–1151.
Google Scholar | Crossref | Medline35. Son, H, Kim, J, Kim, C, et al. Clinical and economic impact of medication reconciliation in cancer patients: a systematic review. Eur J Hosp Pharm 2018; 25: 21–25.
Google Scholar | Crossref | Medline36. Pharmaceuticel Care Network Europe . Position Paper on the PCNE definition of Medication Review 2016, https://www.pcne.org/upload/files/149_Position_Paper_on_PCNE_Medication_Review_final.pdf (2016, accessed 22 April 2020).
Google Scholar37. Hanlon, JT, Schmader, KE. The medication appropriateness index at 20: where it started, where it has been, and where it may be going. Drugs Aging. 2013; 30: 893–900.
Google Scholar | Crossref | Medline | ISI